Morning Overview on MSN
New prostate cancer immunotherapy slashes biomarkers by up to 99%
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
Investigators sought to determine the effect of “Smart PSA” guidelines on screening behavior and biopsy outcomes among Black men.
Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.
It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.
Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...
The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...
While many people are familiar with mammograms and smear tests, prostate screening is talked about far less.To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, ...
A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...
When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery Wendy Grossman Kantor is an award-winning journalist who has contributed to PEOPLE ...
He connected with Dr. James Porter, Chief Medical Officer for Robotic and Digital Technologies at Medtronic, who suggested Choate-Deeds join a clinical trial for Hugo, a robotic-assisted surgery ...
In fact, urinary-related symptoms are common — particularly as men age — and a majority of the time, they're not an indication of cancer. “The prostate naturally grows over time, which can narrow the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results